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Unilamellar phosphatidylcholine/cholesterol (5:1, w/w) vesicles and the fluorescent dye safranine O mixed 
in appropriate ratios produced a membrane potential-dependent hancement of dye fluorescence. The 
fluorescence nhancement was shown to be dependent on the sign and magnitude of valinomycin-induced 
potassium diffusion potentials. The enhancement and a blue-shifted maximum (both of which also occur 
in ethanol vs aqueous olution) provided evidence that the enhanced fluorescence arises from an additional 
population of safranine O molecules which become associated with a hydrophobic region of the vesicular 
membrane. Consistent with this interpretation, the polarization of safranine O fluorescence was also found 
to increase in a potential-dependent manner. A time-dependent decay of the fluorescence nhancement - 
presumably due to decay of the membrane potential - was attributed to non-specific ion leakage at valino- 
mycin concentrations above 3/zM. 
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1. INTRODUCTION 
Safranine O (scheme l) is a potential-sensitive 
fluorescent dye suitable for spectroscopic detection 
of a membrane potential in cellular and vesicular 
membrane systems. Extensive use of this dye has 
been made, particularly in measuring mitochon- 
drial membrane potentials [1,2] as well as poten- 
tials across other cell membrane preparations ([3], 
review [4]). Studies of its behavior have been 
reported in well-defined lipid vesicles prepared by 
an extrusion technique [5], and in cardiolipin- 
containing vesicles [6]. In general, most authors 
have reported quenching of safranine O 
fluorescence in response to a membrane potential 
(negative inside), or changes in absorbance, both 
of which were attributed either to precipitation of 
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the dye (at high concentrations) or stacking of dye 
molecules at internal sites [2,5]. However, using 
relatively lower concentrations of safranine O than 
most previous workers in systems comprised of 
phosphatidylcholine/cholesterol (PC/Chol) vesi- 
cles -300 ,A, in diameter, we have observed signifi- 
cant increases in safranine O fluorescence which 
are sensitive to both the sign and magnitude of the 
membrane potential. The molecular events 
underlying this fluorescence enhancement 
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Scheme 1. Structure of safranine O. 
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phenomenon - originally noted in a study of active 
transport in membrane vesicles from E. coli [7] - 
and its time-dependent decay, are discussed herein. 
2. MATERIALS AND METHODS 
2.1. Preparation of  unilamellar vesicles 
Egg PC (Avanti Polar Lipids, Birmingham, AL) 
and Chol (Sigma) in appropriately weighed ratios 
(normally 5:1 PC/Chol,  w/w) were mixed and 
dissolved in chloroform. Evaporation of solvent 
under nitrogen left a lipid film which was further 
dried for 1 h under vacuum. An aliquot of the 
solution to be included in the vesicles' inner com- 
partment was added to produce a final lipid con- 
centration of -15 mg/ml (PC). Typically, this 
solution was 150 mM KCI, 5 mM Hepes, 1 mM 
EDTA (pH 7.0) except where the major cation or 
anion was changed as noted. This suspension was 
vortex-mixed for 1 min and then sonicated in a 
Branson bath sonicator at room temperature under 
nitrogen until the solution became clear. These 
procedures yielded essentially unilamellar vesicles 
(300 A diameter) as judged by negative staining 
electron microscopy [8]. Samples of this prepara- 
tion (0.5 ml) were then centrifuged through 3 ml 
Sephadex G-50 (medium) (Pharmacia, Uppsala) 
gel-filtration columns twice in succession ac- 
cording to Neal and Florini [9]. The columns had 
been pre-incubated with the appropriate xternal 
solution (e.g. 149 mM NaCI, 1 mM KCI, 5 mM 
Hepes, 1 mM EDTA; pH 7.0). Lipid concentra- 
tion was then determined by phosphate assay [10] 
for all preparations. Vesicles were further diluted 
with external buffer to the desired concentrations 
in a final volume of 3 ml. Safranine O (Sigma, St. 
Louis, MO) was added typically as 20/A of a 
0.15 mM solution in water. Valinomycin (Fluka, 
Switzerland) was added typically as 20/A of a 
1 mg/ml solution in DMSO. Fluorescence was 
measured on a Spex Instruments fluorolog 2 spec- 
trofluorometer with excitation at 522 nm and 
emission at 581 nm except where noted. 
Polarization measurements were made with an 
Aminco fluorimeter and are the averages of three 
experiments. Polarization was calculated from the 
formula 
P = (Ivv - Ivn)/(/vv + Ivn) 
where the subscripts (V, vertical; H, horizontal) 
refer to the excitation and emission polarizers, 
respectively. A scrambler was employed between 
the emission polarizer and the emission 
monochromator to eliminate the need to correct 
for differences in the efficiency of detection of ver- 
tically and horizontally polarized light. 
3. RESULTS 
Safranine O in the presence of PC/cholesterol 
(5:1, w/w) vesicles gave a steady baseline 
fluorescence which was higher than that observed 
in the absence of vesicles. A plot of safranine O 
fluorescence vs vesicle concentration ( ot shown) 
suggests that this initial fluorescence increase is 
due to low-affinity binding (Ka - 5 x 10 2 M -1) of 
the dye to the lipid vesicles. Addition of the 
K+-specific ionophore valinomycin to vesicles with 
a K ÷ gradient (150 mM KC1 inside, 1 mM KCI out- 
side) (fig.la) caused a rapid rise in fluorescence 
followed by a slow return to baseline over the 
course of several minutes. Samples prepared in ex- 
actly the same way but without a K ÷ gradient 
( !50mM KC1 inside and outside) showed no 
change in fluorescence when valinomycin was add- 
ed (fig.lb). Control experiments demonstrated 
that DMSO added in the amounts used to add 
valinomycin had no effect. The direction of the K ÷ 
gradient was critical, however; vesicles onicated in 
NaC1 solution and eluted through columns in KCI 
buffers (which produces a 'negative outside' 
potential when valinomycin is added) showed no 
changes in fluorescence. Furthermore, as an- 
ticipated from the known K ÷ selectivity of 
valinomycin, an Na ÷ gradient of the same sign and 
magnitude (as for K ÷ in fig.la) produced by 
sonicating vesicles in NaCl solution and passing 
them through a choline chloride column also did 
not induce the fluorescence increase. 
The valinomycin-induced fluorescence increase 
was found to be sensitive to the magnitude of the 
K ÷ gradient. If it is assumed that valinomycin 
renders the vesicle membrane much more 
permeable to K ÷ than to any other ions [11], the in- 
itial membrane potential can be calculated from 
the Nernst equation: 
zl~ = RT/zF  In ([K+]out/[K+]in) (1) 
By varying the external K + concentration, [K+]out, 
we generated a series of membrane potentials as 
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Fig. 1. Potential-induced fluorescence nhancement of
safranine O (1/zM) in the presence of unilamellar 
PC/Chol (5 : 1, w/w) vesicles. (a) Valinomycin (20/A of 
1 mg/ml solution in DMSO) added at time = 0 to 
PC/Chol vesicles (1 mg/ml) containing 150 mM KC1 
inside, suspended in external buffer containing 1 mM 
KCI. (b) Same as (a), but with 150 mM KC1 both inside 
and outside vesicles. See section 2 for further details. 
Fluorescence of safranine O measured at 581 nm. Chart 
recording was halted during valinomycin additions. 
shown in fig.2, where the magnitude of the ob- 
served fluorescence increase (taken at the max- 
imum in each curve) is plotted vs calculated 
potential (eqn 1). The overall shape of the curve is 
sigmoidal but the region between 80 and 150 mV 
can be approximated by a straight line. The shape 
of this curve corresponds exactly to what would be 
predicted if the free energy of binding of the dye 
is proportional to the transmembrane potential 
(eqn 2): 
AGassoc = k(A•) + AGo (2) 
where AGo is the intrinsic binding energy in the 
absence of a potential and k is a proportionality 
constant. (We note that AGassoc = RT]nKassoc, 
where Kasso¢ is given by [D]b/[D]f[L]. In this ex- 
pression, [D]b is the concentration of bound dye, 
[D]f the concentration of free dye, and [L] is the 
concentration of unoccupied binding sites. One 
can thus calculate Kassoc as a function of A~k by 
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Fig.2. Intensity observed experimentally for potential- 
induced safranine O fluorescence vsmembrane potential 
calculated using [K+]out, [K+]in and the Nernst equation 
(see text and eqn 1). 
combining eqns 1 and 2. Since the total dye con- 
centration is known, the relative amounts of 
bound and free dye can be calculated at a given 
potential.) A plateau is reached when either all the 
dye is bound or all binding sites are saturated. 
That the potential-induced increase in 
fluorescence is due to accumulation of safranine O 
molecules into a non-polar region of the vesicle 
membrane is supported by two further observa- 
tions. First, as shown in fig.3, safranine O 
fluorescence in the less polar medium ethanol is 
much more intense than in water. Secondly, 
measurements of the valinomycin-induced 
fluorescence increase over baseline at various 
wavelengths, hown in fig.4, demonstrate hat the 
fluorescence mission maximum wavelength of 
membrane-associated dye is blue-shifted. The 
wavelength of maximum fluorescence of the dye is 
similarly blue-shifted -20  nm in ethanol vs water 
(fig.a). 
We considered the possibility that the observed 
fluorescence nhancement is due to changes in 
quantum yield of (the low-affinity) bound dye 
rather than to changes in the extent of safranine O 
binding per se. However, this is unlikely to be the 
case since (i) the observed changes in fluorescence 
are relatively large (up to 100°70) while most known 
effects of membrane potential on quantum yield 
are much smaller [12]; (ii) at higher dye concentra- 
tions (10/~M), we noted (by fast separation of 
339 
Volume 224, number 2 FEBS LETTERS November 1987 
C 
¢0 
w 
.= 
,=  
B 
u 
530 590 650 
Wave length  (nm)  
Fig.3. Fluorescence spectrum of safranine O (1/zM) (a) 
in KC1 buffer and (b) in ethanol. Excitation at 522 nm. 
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Fig.5. Conditions are as given in fig.la except hat the 
sample was excited with vertically polarized light. 
Emission was measured with the polarizer either 
vertically or horizontally. Polarization was calculated as 
outlined in section 2. Results are the average of three 
experiments. 
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Fig.4. Wavelength dependence of safranine O potential- 
induced fluorescence intensity in the presence of 
PC/Chol vesicles. Intensity is measured as the maximum 
fluorescence minus the baseline at each wavelength. 
Experimental conditions are as given in fig.la, but 
emission wavelength was varied as indicated. 
vesicles f rom the surrounding solut ion using mini 
gel- f i l trat ion columns) that the amount  of  vesicle- 
associated dye is qual itat ively greater in those 
vesicles with an ion gradient,  indicating the intrin- 
sic capacity of  the vesicles to take up addit ional  
dye in the concentrat ion range 1-10/zM;  and (iii) 
safranine O f luorescence polar izat ion was found to 
increase signif icantly when val inomycin was added 
to vesicles having a t ransmembrane potent ial  
(fig.5). Also,  the time course observed in polar iza- 
t ion experiments was the same as with total  
f luorescence. This latter behaviour is consistent 
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Fig.6. Potential-induced fluorescence nhancement of 
safranine O in the presence of PC/Chol vesicles. The 
volume of valinomycin solution (1 mg/ml in DMSO) 
added (at time = 0) was varied as shown from 10/A to 
80/zl. Experimental conditions are as given in fig.la. 
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with increased binding of safranine O to vesicles 
and consequent slowing of the rotational motion 
of the dye. A study by Waggoner et al. [13] sug- 
gested that a similar type of partitioning is respon- 
sible for the potential-dependent changes in 
fluorescence of a cyanine dye (diS-C2-(5)). 
The decay in fluorescence is facilitated by 
valinomycin in a concentration-dependent manner 
as can be seen in fig.6. (Importantly, valinomycin 
added as a 10/zl aliquot to this system produces a
relatively stable enhanced fluorescence; fig.6a.) 
Yet this effect does not depend on the presence of 
safranine O; timed addition of the dye after addi- 
tion of valinomycin (not shown) demonstrated that 
the fluorescence decays in the same manner in the 
absence of the dye. 
4. DISCUSSION 
The increases in fluorescence observed in the 
present experiments appear firstly to be due to our 
use of one to three orders of magnitude lower con- 
centration of safranine O (e.g. see [5]), since in our 
system, the formation of dimers or multimers 
(stacking) which decrease fluorescence should be 
minimal. Stacking has been shown to occur as the 
dye concentration approaches 1 mM [14], whereas 
we have used a dye concentration of 1/~M in the 
present experiments. Given the intrinsic Ka of 5 X 
10 -z M -1 (vide infra), the initial bound dye con- 
centration is calculated as -0.18/~M. We also 
noted that fluorescence intensity displays a nearly 
linear dependence on dye concentration in this 
range (not shown), further suggesting that 
safranine O self-association does not occur. At 
high concentrations, binding of safranine O to 
lipid may already be saturated so that the specific 
effects of changes in membrane potential on dye 
fluorescence would accordingly be smaller. In the 
present system, we therefore conclude that crea- 
tion of the membrane potential enhances dye 
fluorescence essentially by inducing further parti- 
tioning (additional to the 'low-affinity' initial 
binding) of the dye into the membrane. 
While the mechanism of the fluorescence decay 
remains to be elucidated fully, we showed that 
specific transport of other ions by valinomycin 
probably does not occur. Thus, Na + can be replac- 
ed by (larger) choline + in the external solution with 
little effect on decay rates. In addition, C1- can be 
replaced by (less permanent) SO42- without effect. 
Safranine O fluorescence is insensitive to pH per 
se, so that small pH changes which might occur in 
our weakly buffered system would also not affect 
fluorescence directly. Since the initial height of the 
potential-dependent fluorescence enhancement re- 
mains essentially constant over a range of 
valinomycin concentrations (fig.6), it is unlikely 
that increasing amounts of intramembranous 
valinomycin interfere or compete with safranine O 
binding. Also, since all concentrations of 
valinomycin cause fluorescence decay to the same 
baseline, formation of a valinomycin-safranine O 
complex of decreased fluorescence is unlikely. 
Thus, the source of the potential decay appears to 
be non-specific ion leakage due to membrane 
disruption (and hence, potential decay) caused by 
increasing concentrations of valinomycin (i.e. 
greater than a bulk concentration of 3/zM as in 
fig.6, 10/A curve). 
The presence of a variety of lipids (as well as 
proteins) in biological membranes could affect the 
number and affinity of binding sites for dyes such 
as safranine O. Further, the fluorescence yield of 
the dye may vary at different binding sites (e.g. 
some sites may promote dimerization of safranine 
O and thus fluorescence quenching). Nevertheless, 
the present work reaffirms the property of small 
molecules to be 'driven' into membrane microen- 
vironments in response to a membrane potential. 
Similar phenomena may affect the binding in vivo 
of lipophilic/cationic molecules - such as 
neurotransmitters and neuropeptides - to cellular 
membranes. 
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